Assistant Professor of , University Alabama
Cardiology
Dr. Jose A. Tallaj, MD
|
|
Give Review
Jose Tallaj practices Cardiology. He went to medical school at Wayne State University School of Medicine. Wayne State University School of Medicine is ranked 63/85 in Research/PrimaryCare. He received awards:"Regional Top Doctor", "Meaningful Use Stage 1 Certification" and "Fellow (FACC)". Jose Tallaj is a published doctor. He published 55 publications, including: 'Infections, Arrhythmias, and Hospitalizations on Home Intravenous Inotropic Therapy.' Jose A. Tallaj accepts Medicare.
Publications
- Assessing continuous renal replacement therapy as a rescue strategy in cardiorenal Syndrome 1.
- Have risk factors for mortality after Heart transplantation changed over time? Insights from 19 years of Cardiac Transplant Research Database study.
- Octreotide in the Mangement of Recurrent Gastrointestinal Bleed in Patients Supported by Continuous Flow Left Ventricular Assist Devices.
- "Cancer in end stage Heart failure patients supported by left ventricular assist devices: Case series."
- The 3D transoesophageal echocardiography role in the Impella 3.5 placement.
- Infection and Rejection Risk After Cardiac Transplantation Comparing Induction with Interleukin II Receptor blocker, Antithymocyte Globulin, or No Induction: a multi -...
- Therapeutic plasma exchange rapidly improves cardiac allograft function in patients with presumed antibody-mediated rejection.
- A multi-institutional study of malignancies after Heart transplantation and a comparison with the general United States population.
- Single-center experience with extracorporeal photopheresis in pediatric Heart transplantation.
- Outcomes of Patients with Peripartum Cardiomyopathy Who Received Mechanical Circulatory Support: Data from the INTERMACS Registry.
- Chymase mediates angiotensin-(1-12) metabolism in normal human Hearts.
- Opportunities for improvement in Heart transplantation outcomes for young adults 18 to 35 years of age.
- Improvement in 2-year survival for ventricular assist device patients after implementation of an intensive surveillance protocol.
- Mechanical rescue of the Heart in shock.
- Minimizing infection and rejection death: clues acquired from 19 years of multi-institutional cardiac transplantation data.
- Use of gated cardiac computed tomography angiography in the assessment of left ventricular assist device dysfunction.
- Balancing rejection and infection with respect to age, race, and gender: clues acquired from 17 years of cardiac transplantation data.
- Device related infections: are we making progress?
- Bradycardia and Syncope as a presentation of cardiac allograft rejection involving the conducting system.
- Transforming growth factor-beta polymorphisms and cardiac allograft rejection.
- Safety and efficacy of ibutilide in Heart transplant recipients.
- Invasive monitoring in patients with Heart failure.
- Implantable hemodynamic monitors.
- Treprostinil-based therapy in the treatment of moderate-to-severe Pulmonary arterial hypertension: long-term efficacy and combination with bosentan.
- Use of an intraperitoneal ventricular assist device with a polytetrafluoroethylene barrier decreases infections.
- Post-Heart transplant diastolic dysfunction is a risk factor for mortality.
- Alterations in the fibrinolytic cascade post-transplant: evidence of a bimodal expression pattern.
- Left ventricular eccentric remodeling and matrix loss are mediated by bradykinin and precede cardiomyocyte elongation in rats with volume overload.
- Acute take-off of the right coronary artery with long intra-aortic wall course presenting as chronic coronary ostium occlusion in a patient with end-stage heart failure.
- Efficacy of bosentan in a small cohort of adult patients with pulmonary arterial hypertension related to congenital heart Disease.
- Ultrafiltration: a new approach toward mechanical diuresis in Heart failure.
- Response of doxorubicin-induced Cardiomyopathy to the current management strategy of heart failure.
- Multi-organ transplantation: is there a protective effect against Acute and chronic rejection?
- Re-stenosis of a sirolimus-coated stent in a Heart transplant recipient with allograft vasculopathy.
- Managing device infections: are we progressing or is infection an insurmountable obstacle?
- Report from a consensus conference on antibody-mediated rejection in Heart transplantation.
- Cardiovascular events in patients with fabry Disease natural history data from the fabry registry.
- Assessment of functional outcomes using the 6-minute walk test in cardiac rehabilitation: comparison of patients with and without left ventricular dysfunction.
- Rejection with hemodynamic compromise: objective evidence for efficacy of photopheresis.
- Angiotensin II modulates catecholamine release into interstitial fluid of canine myocardium in vivo.
- The use of technetium-99m sestamibi in a patient with liver cirrhosis.
- Extracardiac localization of technetium 99m sestamibi.
- Use of Retrospectively Gated CT Angiography to Diagnose Systolic LVAD Inflow Obstruction.
- Comparison of observed survival after ventricular assist device placement versus predicted survival without assist device using the Seattle Heart failure model.
- The safety of bivalirudin during elective percutaneous Coronary interventions in heart transplant patients.
- Xenograft calcification in Reiter''s Syndrome.
- A propensity-matched study of the association of low serum potassium levels and mortality in Chronic heart failure.
- Re-stenosis after drug-eluting stents in cardiac allograft vasculopathy.
- Left ventricular collapse secondary to pericardial effusion treated with pericardicentesis and percutaneous pericardiotomy in severe Pulmonary hypertension.
- Cardiac interstitial bradykinin and mast cells modulate pattern of LV remodeling in volume overload in rats.
- Selection of patients and techniques of Heart transplantation.
- Palliation of allograft vasculopathy with transluminal angioplasty: a decade of experience.
- Left Ventricular Diastolic Function and Exercise Capacity in Community-Dwelling Adults ???65 Years of Age Without Heart Failure.
- Infections, Arrhythmias, and Hospitalizations on Home IntraVenous Inotropic Therapy.
Schools
Pontificia Universidad Catolica Madre Y Maestra Pucmm Facultad De Ciencias De La Salud
Wayne State University
Wayne State UDetroit Med Center
University Ala
Procedures Preformed
- Ablation for Treatment of Cardiac Arrhythmias
- Automatic Implantable Cardioverter Defibrillator (ICD) Implantation
- Cardiac Catheterization (incl. Coronary Angiography)
- Cardiac Imaging
- View All
Conditions Treated
- Acute Venous Embolism Thrombosis
- Angina and Acute Coronary Syndrome
- Aortic Aneurysm
- Aortic Valve Disease
- View All
Doctors Specialties
- Cardiology
Accepted Insurances
- Aetna
- Blue Card PPO
- Dental Blue 100/200/300
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access Plus
- Commercial Insurance Company
- First Health (Coventry Health Care) PPO
- Choice Care PPO
- Kaiser Permanente
- Mail Handlers Benefit Plan (MHBP)
- Medicare MCR
- MultiPlan PPO
- Mutual of Omaha
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- United Healthcare
Awards
- Regional Top Doctor
- Meaningful Use Stage 1 Certification
- Fellow (FACC)
Education
-
University of Alabama Medical Center -
Wayne State University School of Medicine
Hospital
-
University of Alabama Hospital -
Birmingham Veterans Affairs Medical Center
Drug Facts
| NPI NUMBER | 1790705978 | |
| NPPES Provider LastName | TALLAJ | |
| NPPES Provider FirstName | JOSE | |
| NPPES Provider ZIPCode | 35233 | |
| NPPES Provider State | AL | |
| Specialty Description | Cardiology | |
| Total Claim Count | 7571.0 | |
| Distinct Opioid Count | 2.0 | |
| Opioid Claim Count | 157.0 | |
| Percent Opioid Claims | 2.07 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1790705978 |
| Last Name Of The Provider | TALLAJ |
| First Name Of The Provider | JOSE |
| View All |
Similar Doctors
|
|
Dr. Robert K. Lewis, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Hugh T. McElderry Jr., MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. James T. White, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. William R. Harrison, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. John T. Eagan Sr., MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kevin B. Deandrade, MD |
|
|
Dr. Anthony A. Cibulski, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Robert E. Foster, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jimmie L. Dotson Jr., MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Brigitta C. Brott, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. William A. MacLean, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Van C. Reeder, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Himanshu Gupta, MD |
|
|
Dr. Farrokh F. Seghatol-Eslami, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Rajesh Venkataraman, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. John C. Gulotta, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Samuel K. McElwee, MD
This Doctor is OpenDoctor Recommended.
|